Hexagon Nutrition
· Mainboard · NSE, BSE
Price Band
₹42–45
Lot Size
333 shares
Issue Size
₹139 Cr
Min. Investment
₹14,985
Grey Market Premium
Indicative, updates through the day
Estimated listing price: ₹45
Subscription Status
About Hexagon Nutrition
Incorporated in 1993, Hexagon Nutrition Ltd. is a research-driven nutrition company. It is engaged in developing and manufacturing products across micronutrient premixes, branded wellness and clinical nutrition, therapeutic formulations, and ready-to-use foods. The company operates three manufacturing facilities in India, located at Nasik (Maharashtra), Chennai (Tamil Nadu), and Thoothukudi (Tamil Nadu), along with an international unit in Tashkent, Uzbekistan. Two Indian facilities are situated in SEZ zones at Chennai and Thoothukudi, providing strategic advantages such as proximity to ports and duty-free imports. Its product portfolio is classified into three segments: Hexagon Nutrition has a PAN-India omnichannel distribution network covering retail pharmacies, hospital networks, e-commerce platforms, online pharmacies, and its own branded websites including Pentasure, Obesigo, Pediagold, and Nutrone. For domestic distribution, it works with over 358 distributors across India, including 8 with multi-state presence. The company has established overseas offices in South Africa, Uzbekistan, and Hong Kong to support international operations. Its products have been exported to more than 75 countries across Asia, Africa, Europe, and South America between fiscals 2023 and 2025. Hexagon Nutrition maintains two dedicated in-house R&D facilities at Nasik and Chennai, supported by a team of 12 qualified professionals. As of March 31, 2026, the company employed 527 people.
Anchor Investors
Hexagon Nutrition IPO raises ₹41.66 crore from anchor investors. Hexagon Nutrition IPO Anchor bid date is June 4, 2026.
Reservation
| Category | Shares Offered | % |
|---|---|---|
| QIB | 1,54,29,851 | 50% |
| − Anchor Investor | 92,57,696 | 30% |
| − QIB (Ex. Anchor) | 61,72,155 | 20% |
| NII (HNI) | 46,28,956 | 15% |
| − bNII > ₹10L | 30,85,971 | 10% |
| − sNII < ₹10L | 15,42,985 | 5% |
| Retail | 1,08,00,897 | 35% |
- QIB30.3%
- − Anchor Investor18.2%
- − QIB (Ex. Anchor)12.1%
- NII (HNI)9.1%
- − bNII > ₹10L6.1%
- − sNII < ₹10L3.0%
- Retail21.2%
Market Lot Size
| Application | Lots | Shares | Amount |
|---|---|---|---|
| Retail (Min) | 1 | 333 | ₹14,985 |
| Retail (Max) | 13 | 4329 | ₹1,94,805 |
| S-HNI (Min) | 14 | 4662 | ₹2,09,790 |
| S-HNI (Max) | 66 | 21978 | ₹9,89,010 |
| B-HNI (Min) | 67 | 22311 | ₹10,03,995 |
Financials (₹ Cr)
Valuations
EPS (Pre IPO)
1.98
EPS (Post IPO)
2.93
ROE
12.12%
P/E (Pre IPO)
22.69
P/E (Post IPO)
15.35
Price / Book
2.48
Market Cap
₹553.13 Cr.
Peers Comparison
| Company | P/E | ROE | Revenue |
|---|---|---|---|
| Sai Parenteral's Ltd. | 72.19 | ₹408.79 Cr | |
| Corona Remedies Ltd. | 43.47 | ₹655.37 Cr | |
| Rubicon Research Ltd. | 55.75 | ₹1,377.50 Cr | |
| Amanta Healthcare Ltd. | 34.59 | ₹126.00 Cr | |
| Anlon Healthcare Ltd. | 17.67 | ₹121.03 Cr | |
| Bio Medica Laboratories Ltd. | 13.03 | ₹52.43 Cr |
Contact Details
Hexagon Nutrition Ltd. Address
- +91 22 6213 6710
- cs.hnpl@hexagonnutrition.com
- https://hexagonnutrition.com/
Registrar Contact Details
KFin Technologies Ltd.
- +91 40 6716 2222
- einward.ris@kfintech.com
- https://kfintech.com
- Selenium Tower B, Plot 31-32, Financial District, Nanakramguda, Hyderabad – 500032
Frequently Asked Questions
Key Dates
- Open Date
- 05 Jun 2026
- Close Date
- 09 Jun 2026
- Listing Date
- 12 Jun 2026
Issue Details
- Registrar
- KFin Technologies
- Lead Manager(s)
- Exchange
- NSE, BSE